Professor Marco Gerlinger

About Professor Marco Gerlinger

Professor Marco Gerlinger is a highly-renowned London-based consultant medical oncologist and cancer researcher. With over two decades of experience, his areas of expertise include colorectal cancer, oesophageal cancer, stomach/gastric cancer, immunotherapy, chemotherapy, and personalised cancer medicine. Professor Gerlinger studied medicine at the University of Munich, Harvard Medical School and Imperial College London and trained in general medicine and oncology in Zurich and London. He obtained a Research MD degree from the University of Munich in 2006 . He currently practises privately at both Leaders in Oncology Care (LOC) at the Harley Street Clinic and Nuffield Health at St Bartholomew’s Hospital. Professor Gerlinger also plays pivotal roles at St Bartholomew's Hospital Cancer Centre, where he serves as the Clinical Director of the GI Oncology Department and Director of GI Cancer Research. He is also the Chair of Gastrointestinal Cancer Medicine at the Barts Cancer Institute at Queen Mary University of London. He serves as a faculty member in GI cancer and immuno-oncology for the European Society of Medical Oncology and the American Society of Clinical Oncology. In addition to his extensive clinical experience, Professor Gerlinger has an impressive background in medical and translation research. He runs the Cancer Immunotherapy and Genomics research laboratory at the Barts Cancer Institute and is a principle or chief investigator of multiple clinical trials. His particular research interest is how immunotherapy can be made more effective in bowel, oesophagus and gastric cancers, and how cure rates in early-stage cancers can be improved by using circulating tumour DNA for treatment personalisation. His research contributions can be found on his ResearchGate profile. He is a member of the American Association of Cancer Research. Professor Gerlinger's extensive experience and deep insights into research ensure the highest level of care for his patients.